Literature DB >> 15363037

Laminin 5 beta3 and gamma2 chains are frequently coexpressed in cancer cells.

Shingo Akimoto1, Yukihiro Nakanishi, Michiie Sakamoto, Yae Kanai, Setsuo Hirohashi.   

Abstract

Laminin 5 plays an important role in cell migration during tumor invasion and tissue remodeling. However, previous studies have not clarified whether laminin 5 beta3 chain is coexpressed with laminin 5 gamma 2 chain in cancer cells. The present immunohistochemical study investigated the distribution of the laminin 5 beta3 and gamma2 chains in 20 cases of squamous cell carcinoma of the tongue and 17 cases of colorectal carcinoma. Laminin 5 beta3 and gamma2 chains were expressed in the cytoplasm of tumor cells. Tumor cells at the cancer-stromal interface and at the invasive front frequently showed immunopositivity for laminin 5 beta3 and gamma2 chains in both squamous cell carcinoma of the tongue and colorectal carcinoma. Furthermore, strong expressions of these two proteins were observed in cancer cells invading in a scattered manner. Laminin 5 beta3 expression correlated significantly with laminin 5 gamma2 expression in 20 cases of squamous cell carcinoma of the tongue (P = 0.0002) and 17 cases of colorectal carcinoma (P < 0.0001). These results suggest that in squamous cell carcinoma of the tongue and colorectal carcinoma, laminin 5 gamma2 chain and beta3 chain are both important in the invasiveness of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363037     DOI: 10.1111/j.1440-1827.2004.01681.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  9 in total

1.  Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma.

Authors:  Cheng Wang; Hongzhang Huang; Zhiquan Huang; Anxun Wang; Xiaohua Chen; Lei Huang; Xiaofeng Zhou; Xiqiang Liu
Journal:  J Oral Pathol Med       Date:  2011-04-12       Impact factor: 4.253

2.  Embryonic vasculogenesis in nodular melanomas and tumour differentiation.

Authors:  Bhanu Iyengar; Avantika V Singh
Journal:  Pathol Oncol Res       Date:  2011-01-04       Impact factor: 3.201

3.  Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.

Authors:  Toshikuni Oka; Hiroyuki Yamamoto; Shigeru Sasaki; Masanori Ii; Keiichi Hizaki; Hiroaki Taniguchi; Yasushi Adachi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

4.  Laminin expression in advanced laryngeal squamous cell carcinoma does not correlate to neck metastases.

Authors:  Daniela Mielcarek-Kuchta; Jan Olofsson; Wojciech Golusinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-31       Impact factor: 2.503

Review 5.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

6.  Overexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Jun Chen; Hao Zhang; Jiansheng Luo; Xiaokang Wu; Xueming Li; Xinyi Zhao; Dongkai Zhou; Shian Yu
Journal:  Oncol Lett       Date:  2018-05-09       Impact factor: 2.967

7.  Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.

Authors:  Chantragan Srisomsap; Phannee Sawangareetrakul; Pantipa Subhasitanont; Daranee Chokchaichamnankit; Khajeelak Chiablaem; Vaharabhongsa Bhudhisawasdi; Sopit Wongkham; Jisnuson Svasti
Journal:  J Biomed Biotechnol       Date:  2009-12-27

8.  Divergent mechanisms underlie Smad4-mediated positive regulation of the three genes encoding the basement membrane component laminin-332 (laminin-5).

Authors:  Dirk Zboralski; Miriam Böckmann; Marc Zapatka; Sabine Hoppe; Anna Schöneck; Stephan A Hahn; Wolff Schmiegel; Irmgard Schwarte-Waldhoff
Journal:  BMC Cancer       Date:  2008-07-29       Impact factor: 4.430

9.  Overexpression of β3 Chains of Laminin-332 is Associated With Clinicopathologic Features and Decreased Survival in Patients With Pancreatic Adenocarcinoma.

Authors:  Jun Chen; Weilin Wang; Jianfeng Wei; Dongkai Zhou; Xinyi Zhao; Wei Song; Qiang Sun; Pengfei Huang; Shusen Zheng
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.